Panacea Biotec to supply bivalent oral polio vaccines worth ₹127 cr to CMSS

In a regulatory filing, Panacea Biotec said the CMSS has accepted the company’s offer for supply of bivalent oral polio vaccine against the tender issued by it through a Letter of Acceptance